monoclonal antibody therapy
| 4 min read
Novartis’ iscalimab may improve troubling symptoms in patients with Sjögren’s disease, though there may be safety concerns to address.
Available on Demand
Antibodies that simultaneously target two distinct antigens overcome cancer therapy resistance by addressing antigenic diversity and diminished T cell action.
Page 1 of 1 - 2 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Journeying through cells' spatial dimensions
Spatial biology adds a new layer of knowledge to unsolved biological questions.
A Technology Guide for AI-Enabled Drug Discovery
Learn practical strategies for using artificial intelligence to find the best drug candidate.
Achieving bioanalytical precision and control
Advanced LIMS software helps researchers reliably manage complex bioanalytical workflows and data.
